Sticker Shock: New Research Shows an Average List Price Increase of Over 200% for Top Part D Drugs
Research released by AARP’s Public Policy Institute (PPI), list prices for the top 25 Medicare Part D drugs have increased by an average of 226%.
All News
Getting the Facts: Drug Companies Increasingly Using Patent Games to Avoid Competition
A recent article published by STAT highlights how Big Pharma is using continuation patents to keep lower-cost generic drugs from reaching the market.
New Health Affairs Study: Competition In Pharmaceuticals Leads to Lower Prices, Reduced Drug Spending
A study published in Health Affairs found that new brand-name pharmaceutical competition resulted in decreases in net prices of existing drugs.
While Patients Feel the Heat, Big Pharma Increases Prices on More Than 100 Products This Month
Drug makers have increased prices on 847 brands so far in 2023.
AHIP Launches New Campaign that Puts Big Pharma on Notice
As Pharma hides the high prices of prescriptions, health insurance providers negotiate lower costs, more affordable choices for Americans